Editorial Team

The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.

Honorary Editors-in-Chief

Hongyang Wang, MD

Eastern Hepatobiliary Surgery Hospital, Shanghai, China

Jinming Yu, MD, PhD

Shandong Cancer Hospital and Institute, Shandong, China

Dongxin Lin, MD

National Cancer Center/Cancer Hospital, Beijing, China

Editor-in-Chief

Xiaomao Guo, MD

Fudan University Shanghai Cancer Center, Shanghai, China

Executive Editor-in-Chief

Zhimin Shao, MD

Fudan University Shanghai Cancer Center, Shanghai, China

Associate Editors-in-Chief

Alfredo Addeo, MD

Oncology Department, University Hospital Geneva, Geneva, Switzerland

Grace K. Dy, MD

Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

Xianghuo He, PhD

Fudan University Shanghai Cancer Center, Shanghai, China

Qunying Lei, MD, PhD

Fudan University Shanghai Cancer Center, Shanghai, China

Leming Shi, PhD

School of Life Sciences and Shanghai Cancer Center, Fudan University, Shanghai, China

Yanhui Xu, PhD

Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

Xianjun Yu, MD

Fudan University Shanghai Cancer Center, Shanghai, China

Editorial Board

Michelle Afkhami, MD

Department of Pathology, City of Hope National Cancer Center, Duarte, CA, USA

Marco Agostini, PhD

Section of Surgery, Department of Surgical Oncology Gastroenterological Sciences, University of Padova, Padova, Italy

Luis Álvarez-Vallina, MD, PhD

Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus, Denmark; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre, Madrid, Spain

Salvatore Annunziata, MD, PhD

Unit of Nuclear Medicine, Department of Imaging, Radiotherapy and Heamatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Gyorgy Baffy, MD, PhD

Department of Medicine, VA Boston Healthcare System and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Armita Bahrami, MD

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA

Editta Baldini, MD

Department of Medical Oncology, San Luca Hospital, Lucca, Italy

Stefan K. Barta, MD, MS

Division of Hematology-Oncology, Perelman School of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Armand Bensussan, PhD

INSERM U976, HIPI, Team 1 "Onco-Dermatology and Therapies", Saint Louis Hospital, Paris, France; Université Paris Cité, IRSL, Paris, France; Institute Godinot, Reims, France

Giada Bianchi, MD

Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Tithi Biswas, MD

Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA

Valentina Boni, MD, PhD

Director of Clinical Research NEXT Madrid, Universitary Hospital QuironSalud Madrid, Madrid, Spain

Joaquim Bosch-Barrera, MD, PhD

Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona, Spain; Department of Medical Sciences, Faculty of Medicine, University of Girona (UdG), Girona, Spain

Emilio Bria, MD

Medical Oncology, Università Cattolica del Sacro Cuore (UCSC), Fondazione Policlinico Universitario A. Gemelli (FPUG), Comprehensive Cancer Center, Roma, Italy

Giuseppe Bronte, MD

Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy

Oronzo Brunetti, MD

Medical Oncology Department, IRCCS IstitutoTumori "Giovanni Paolo II", Bari, Italy

Orazio Caffo, MD

Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy

Michele Caraglia, MD, PhD

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy

Richard D. Carvajal, MD

Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA

Santiago Cepeda, MD, PhD

Department of Neurosurgery, University Hospital Río Hortega, Valladolid, Spain

Joe Y. Chang, MD, PhD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Haiquan Chen, MD, PhD

Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Liang Cheng, MD

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

Petros Christopoulos, MD

Department of Medical Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Medical Center, Heidelberg, Germany

Melvin Lee Kiang Chua, MBBS, FRCR, PhD

Division of Radiation Oncology, National Cancer Centre, Duke-NUS Graduate Medical School, Singapore

Andrew Churg, MD, PhD

Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada

Nils Cordes, MD, PhD

OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, Technische Universität, D-01307 Dresden, Germany; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany

Jesús Corral, MD

Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain

Felipe Couñago, MD, PhD

Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid, Hospital La Luz, Universidad Europea de Madrid, Madrid, Spain

Giuseppe Curigliano, MD, PhD

Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy

Diwakar Davar, MD

Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

Julio Delgado, MD, MS

Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain

Joanna Didkowska, MD, PhD

Department of Epidemiology & Primary Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Justin M. Drake, BS, PhD

Departments of Pharmacology and Urology, University of Minnesota School of Medicine, Minneapolis, MN, USA

Sergey A. Dyshlovoy, PhD

Department of Internal Medicine II and Clinic (Oncology Center), University Cancer Center Hamburg/Martini-Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Thomas Efferth, PhD

Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany

Anna M. Eiring, PhD

Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso (TTUHSC El Paso), El Paso, TX, USA

Franca Fagioli, MD, PhD

Department of Public Health and Pediatrics, University of Turin, Turin, Italy; Department of Pediatric Onco-Hematology, A.O.U Città della Salute e della Scienza, Turin, Italy

Marco Falasca, PhD

Metabolic Signalling Group, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia

Francesco Fiorica, MD, PhD

Department of Radiation Oncology and Nuclear Medicine, AULSS 9 Scaligera, Verona, Italy

Matthieu Foll, PhD

Rare Cancer Genomics Team Leader, Genomics Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France

Davide Franceschini, MD

IRCCS Humanitas Research Hospital- Radiotherapy and Radiosurgery Department, Rozzano, Milan, Italy

Thomas Frauenfelder, MD

Diagnostic and interventional Radiology, University Hospital Zurich, Zurich, Switzerland

Yutaka Fujiwara, MD, PhD

Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Aichi, Japan

Jesus Garcia-Foncillas, MD, PhD

University Cancer Institute “OncoHealth”, University Hospital “Fundacion Jimenez Diaz”, Autonomous University of Madrid, Madrid, Spain

Valentín García-Gutiérrez, MD, PhD

Department of Hematology, Hospital Ramón y Cajal, Madrid, Spain

Ramón García-Sanz, MD, PhD

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain

Vittorio Gebbia, MD, PhD

Medical Oncology Unit, La Maddalena Cancer Center, Palermo, Italy; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy

Alain Gelibter, MD, PhD

Department of Medical Oncology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy

Francesco Giovinazzo, MD, PhD

General Surgery and Liver Transplant Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Armando E. Giuliano, MD, FACS, FRCSEd

Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Francesca Giunchi, MD

Pathology Department, IRCCS Azienda Ospedaliero-Universitaria, Bologna, Italy

William H. Gmeiner, PhD, MBA

Wake Forest Baptist Hospital Cancer Center, Winston-Salem, NC, USA

Gaurav Goyal, MD

Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

Paolo Graziano, MD

Unit of Pathology, IRCSS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italy

Francesco Grossi, MD

Division of Medical Oncology, University of Insubria, Varese, Italy

Nishant Gupta, MD, DABR

Department of Radiology, Columbia University at Bassett Healthcare, Cooperstown, NY, USA

Ariella Hanker, PhD

Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA

Aparna Hegde, MD

Department of Hematology Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA

Andrew Hendifar, MD

Department of Gastrointestinal Malignancies, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Jesús M. Hernández-Rivas, MD, PhD

Department of Medicine, University of Salamanca, Salamanca, Spain; Department of Hematology, Hospital Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL) and Cancer Research Center of Salamanca, Salamanca, Spain

Weiguo Hu, MD, PhD

Institutes of Biomedical Sciences & Shanghai Cancer Center, Fudan University, Shanghai, China

Xichun Hu, MD, PhD

Department of Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China

Xin Hu, PhD

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, China

Per Hydbring, PhD

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

Johji Inazawa, MD, PhD

Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Ciro Isidoro, MD, PhD

Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", Novara, Italy

O. Hans Iwenofu

Department of Pathology & Laboratory Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Marcelo F. Jimenez, MD, PhD

University of Salamanca, Salamanca, Spain Department of Thoracic Surgery, Salamanca University Hospital, Salamanca, Spain

Mercè Jordà, MD, PhD, MBA

Departments of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA

Jonathan A. Kelber, PhD

Department of Biology, California State Univeristy Northridge, Northridge, CA, USA; Developmental Oncogene Laboratory, California State Univeristy Northridge, Northridge, CA, USA

Santosh Kesari, MD, PhD

John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA

V. Suzanne Klimberg, MD, PhD, MSHCT, FACS

Department of Surgery, University of Texas Medical Branch Cancer Center, Galveston, TX, USA

Jonathan P. S. Knisely, MD

Department of Radiation Oncology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA

Eric Ko, MD, PhD

Department of Radiation Oncology, University of Massachusetts Chan Medical School, UMass Memorial Medical Center, Worcester, MA, USA

Bart Koopman, MD, PhD

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Vadim S. Koshkin, MD

Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA

Marianna Kruithof-de Julio, PhD

Urological Research Laboratory, Department of BioMedical Research (DBMR), University of Bern, Bern, Switzerland

Alan Prem Kumar, PhD

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Luigi Maria Larocca, MD

Institute of Pathology, Università Cattolica del S. Cuore, Fondazione Policlinico "A. Gemelli", Rome, Italy

Volker M. Lauschke, PhD, MBA

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

Mikael S. Lindström, PhD

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Aaron Lisberg, MD

Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA

Alessandra Longhi, MD

Department of Osteoncology of bone and soft tissue sarcoma treament and innovative therapy, Istituto Ortopedico Rizzoli, Bologna, Italy

José I. López, MD, PhD

Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain

José Antonio López-Guerrero, PhD

Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, 46009, Valencia, Spain; Department of Pathology, School of Medicine, Catholic University of Valencia "San Vicente Mártir", Valencia, Spain

Jonathan F. Lovell, PhD

Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, USA

Teresa Macarulla, MD, PhD

Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Mirko Marabese, PhD

Department of Oncology, Mario Negri Institute for Pharmacological Research IRCCS, Milan Italy

Dario Marchetti, PhD

Division of Molecular Medicine, Department of Internal Medicine, The University of New Mexico, Health Sciences Center, Albuquerque, NM, USA

Jose J. G. Marin, BSc, PhD

Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Experimental Hepatology and Drug Targeting (HEVEPHARM) & Salamanca Institute for Biomedical Research (IBSAL), Salamanca, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain

Maurizio Martini, MD, PhD

Institute of Pathology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Yosuke Matsuura, MD, PhD

Department of Thoracic Surgical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Joan Maurel, MD, PhD

Department of Medical Oncology, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Spain

Zhiqiang Meng, MD, PhD

Fudan University Shanghai Cancer Center, Shanghai, China

Isabel Merida, PhD

Department of Immunology and Oncology, National Center for Biotechnology/CSIC, Madrid, Spain

Laura Mezquita, MD, PhD

Department of Medical Oncology, Hospital Clinic, Barcelona, Spain

Mari Mino-Kenudson, MD

Department of Pathology, Massachusetts General Hospital, Boston, MA, USA

Cesar A. Moran, MD

Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

Luca Moscetti, MD

Department of Oncology-Hemathology, Azienda Ospedaliero-Universitaria di Modena - Policlinico, Modena, Italy

Leonhard Müllauer, MD, PhD

Department of Pathology, Medical University Vienna, Vienna, Austria

Luciano Mutti, MD, PhD

Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA, USA

Taku Naiki, MD, PhD

Associate Professor, Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Alfons Navarro, PhD

Department of Surgery and Surgical Specializations, Human Anatomy Unit, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

Andrew Nelson, MD, PhD

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA

Joanne Ngeow, BMedSci, MBBS, FRCP, MPH

Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

Seiji Okada, MD, PhD

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Alejandro Olivares-Hernández, MD, PhD

Department of Medical Oncology, University Hospital Complex of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain

Sandra Ortiz-Cuaran, PhD

Cancer Research Center of Lyon / Centre Leon Bérard, Lyon, France

Alessandro Ottaiano, MD

Department of Abdominal Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy

Gaurav Pandey, PhD

Washington University school of Medicine, St. Louis, MO, USA

Edwin Roger Parra Cuentas, MD, PhD

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Weijun Peng, MD

Fudan University Shanghai Cancer Center, Shanghai, China

Godefridus J. Peters, PhD

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), Amsterdam, The Netherlands

Federico Piacentini, MD

Division of Medical Oncology, Dept. of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Modena, Italy

Sharon R. Pine, PhD

Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA

Helmut H. Popper, MD

Institute of Pathology, Medical University of Graz, Graz, Austria

Edward V. Prochownik, MD, PhD

Division of Hematology/Oncology, Children’s Hospital of Pittsburgh and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Javier Puente, MD, PhD

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain

Ibrahim Qaddoumi, MD, MS

Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA

Jacques Raphael, MD, MSc

Department of Oncology, Division of Medical Oncology, London Regional Cancer Program, Western University, London, ON, Canada

Elie Rassy, MD, MSc, MPH

Department of Cancer Medicine, Gustave Roussy Institut, Villejuif, France

Neil Renwick, MBChB, PhD

Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada

Atocha Romero, PharmD, PhD

Medical Oncology Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain

Giulio Rossi, MD, PhD

Pathologic Anatomy, Azienda USL della Romagna, S. Maria delle Croci Hospital of Ravenna and Degli Infermi Hospital of Rimini, Rimini, Italy

Steven P. Rowe, MD, PhD

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Giuseppe Rubini, MD

Nuclear Medicine Unit, University of Bari "Aldo Moro", Ospedale Policlinico di Bari, Bari, Italy

Marco Russano, MD

Department of Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy

Arvind Sahu, MBBS, MD, DM, FRACP

Department of Oncology, Goulburn Valley Health, Shepparton, VIC, Australia

Pierre Saintigny, MD PhD

Department of Medical Oncology, Department of Translational Research and Innovation, the Cancer Research Center of Lyon; Cancer Centre Léon Bérard Lyon, France

Francesca Sanguedolce, MD, PhD

Pathology Unit, Policlinico Riuniti, Department of Clinical and Experimental Medicine, University of Foggia School of Medicine, Foggia, Italy

Eric Santoni-Rugiu, MD, PhD

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Andrea Sartore-Bianchi, MD

Department of Hematology & Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; Department of Oncology & Hemato-Oncology, University of Milano, Milano, Italy

Jack A. Schalken, PhD

Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

Hans-Ulrich Schildhaus, MD

Institute of Pathology, University Hospital Essen & West German Cancer Center, University Medicine Essen, University Duisburg-Essen, Essen, Germany

Nagashree Seetharamu, MBBS, MD

Division of Hematology/Medical Oncology, Department of Medicine at Northwell Health School of Medicine, Lake Success, NY, USA

Arun Seth, PhD

Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

Masood A. Shammas

Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, USA

Siddharth Sheth, MD

Division of Medical Oncology, Department of Otolaryngology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Haval Shirwan, PhD

Department of Child Health and Microbiology and Immunology, NextGen Precision Health, University of Missouri, Columbia, MO, USA

Frank A. Sinicrope, MD, FACP

Department of Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, MN, USA

Angela Spanu, MD

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy

Sanjay K. Srivastava, PhD

Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX, USA

Patrizia Straccia, BD, PhD

Division of Anatomic Pathology and Histology, Fondazione Policlinico Universitario A. Gemelli –IRCCS, Rome, Italy

Shi-Yong Sun, PhD

Department of Hematology and Medical Oncology, Emory Winship Cancer Institute and Emory University School of Medicine, Atlanta, GA, USA

Umang Swami, MD

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA

Fabrizio Tabbò, MD, PhD

Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Torino, Italy

Zhenya Tang, MD, PhD, FACMG

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Carlos Telleria, PhD

Department of Pathology, McGill University and and MGill University Health Center, Montreal, QC, Canada

Alain R. Thierry, PhD

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France; University of Montpellier, Montpellier, France

Han Chong Toh

National Cancer Centre, Singapore

Masakazu Toi, MD, PhD

Department of Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto University, Kyoto, Japan

Giorgio Treglia, MD, MSc (HTA)

Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Belllinzona, Switzerland; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland